glp-1 ras Emerging Trends in the Development of Receptor Agonists Comprehensive Overview of GLP-1 RAs
Description
By Michael S
People who want a simple, visual food guide
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.
- Mechanism of Action & Protocol.
The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.
Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)
